Barriers to accurately assessing prescription opioid misuse on surveys

References

• Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–52. doi:10.15585/mmwr.mm655051e1
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314(14):1468–78. doi:10.1001/jama.2015.11859
   PubMed Web of Science ®Google Scholar
• Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997;167:17–36.
   PubMedGoogle Scholar
• Johnson T, Fendrich M. Modeling sources of self-report bias in a survey of drug use epidemiology. Ann Epidemiol. 2005;15(5):381–89. doi:10.1016/j.annepidem.2004.09.004
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Shearston JA, Cleland CM. Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors. Am J Drug Alcohol Abuse. 2016;42(5):530–38. doi:10.1080/00952990.2016.1178269
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Le A, Cleland CM. Nonmedical opioid use among electronic dance music party attendees in New York City. Drug Alcohol Depend. 2018;186:226–32. doi:10.1016/j.drugalcdep.2018.03.001
   PubMed Web of Science ®Google Scholar
• Fischer B, Ialomiteanu A, Boak A, Adlaf E, Rehm J, Mann RE. Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada. Drug Alcohol Rev. 2013;32(3):276–87. doi:10.1111/dar.12025
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Acosta P, Calderon FF, Sherman S, Cleland CM. Assessing self-reported use of new psychoactive substances: the impact of gate questions. Am J Drug Alcohol Abuse. 2017;43(5):609–17. doi:10.1080/00952990.2017.1322094
   PubMed Web of Science ®Google Scholar
• Center for Behavioral Health Statistics and Quality. national survey on drug use and health: methodological summary and definitions. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016. [accessed 2018 Jul 28]. https://www.samhsa.gov/data/sites/default/files/NSDUH-MethodSummDefs-2016/NSDUH-MethodSummDefs-2016.htm
   Google Scholar
• Biondo G, Chilcoat HD. Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever. Drug Alcohol Depend. 2014;134:396–400. doi:10.1016/j.drugalcdep.2013.10.005
   PubMed Web of Science ®Google Scholar
• Ruhm CJ. Geographic variation in opioid and heroin involved drug poisoning mortality rates. Am J Prev Med. 2017;53(6):745–53. doi:10.1016/j.amepre.2017.06.009
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Shearston JA, Dawson EW, Mateu-Gelabert P, Ompad DC. Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug Alcohol Depend. 2016;158:132–38. doi:10.1016/j.drugalcdep.2015.11.005
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services, National Institutes of Health. National Institute on Drug Abuse, United States Department of Health and Human Services, Food and Drug Administration. Center for tobacco products codebook for wave 1: adult questionnaire data with weights. Ann Arbor, MI: Inter-university Consortium for Political and Social Research; 2018. [accessed 2018 Jul 28]. https://www.icpsr.umich.edu/icpsrweb/NAHDAP/studies/36231/datadocumentation#
   Google Scholar
• Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Hawkins J, Queen B, et al. Youth risk behavior surveillance - United States, 2015. MMWR Surveill Summ. 2016;65(6):1–174. doi:10.15585/mmwr.ss6506a1
   Web of Science ®Google Scholar
• Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the future national survey results on drug use, 1975-2016: volume I, secondary school students. Ann Arbor: Institute for Social Research, The University of Michigan; 2017. [accessed 2018 Jul 28]. http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2016.pdf
   Google Scholar
• Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. [accessed 2018 Jul 28]. http://www.who.int/substance_abuse/publications/assist/en/
   Google Scholar
• Chan B, Lopez A, Sarkar U. The canary in the coal mine tweets: social media reveals public perceptions of non-medical use of opioids. PLoS One. 2015;10(8):e0135072. doi:10.1371/journal.pone.0135072
   PubMed Web of Science ®Google Scholar
• Harocopos A, Allen B, Paone D. Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City. Int J Drug Policy. 2016;28:106–12. doi:10.1016/j.drugpo.2015.12.021
   PubMed Web of Science ®Google Scholar
• Agnich LE, Stogner JM, Miller BL, Marcum CD. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addict Behav. 2013;38(9):2445–49. doi:10.1016/j.addbeh.2013.03.020
   PubMed Web of Science ®Google Scholar
• Lessler JT, Caspar RA, Penne MA, Barker PR. Developing computer assisted interviewing (CAI) for the national household survey on drug abuse. J Drug Issues. 2000;30(1):9–33. doi:10.1177/002204260003000102
   Web of Science ®Google Scholar
• Gfroerer J, Lessler J, Parsley T. Studies of nonresponse and measurement error in the national households survey on drug abuse. In: Harrison L, Hughes A, (editors.). The validity of self-reported drug use: improving the accuracy of survey estimates: NIDA research monograph. Rockville, MD: U.S. Department of Health and Human Services, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research, 1997: 273–95
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2017. Lisbon. [accessed 2018 Jul 28]. http://www.emcdda.europa.eu/edr2017
   Google Scholar
• U.S. Drug Enforcement Administration. 2017 Emerging Threat Report.[accessed 2018 Jul 28]. https://ndews.umd.edu/sites/ndews.umd.edu/files/dea-emerging-threat-report-2017-annual.pdf
   Google Scholar
• Palamar JJ, Martins SS, Su MK, Ompad DC. Self-reported use of novel psychoactive substances in a us nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend. 2015;156:112–19. doi:10.1016/j.drugalcdep.2015.08.028
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Blanco C, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. Adults Ann Intern Med. 2018;168(5):383–84. doi:10.7326/M17-0865
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration, Office of Diversion Control. 1970. Title 21 United States Code (USC) controlled substances act [accessed 2018 Jul 28]. https://www.deadiversion.usdoj.gov/21cfr/21usc/802.htm
   Google Scholar
• Martins SS, Santaella-Tenorio J, Marshall BD, Maldonado A, Cerda M. Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users. Drug Alcohol Depend. 2015;151:278–83. doi:10.1016/j.drugalcdep.2015.03.020
   PubMed Web of Science ®Google Scholar
• McCabe SE, Schulenberg JE, O’Malley PM, Patrick ME, Kloska DD. Non-medical use of prescription opioids during the transition to adulthood: a multi-cohort national longitudinal study. Addiction. 2014;109(1):102–10. doi:10.1111/add.12347
   PubMed Web of Science ®Google Scholar
• Zacny JP, Lichtor SA. Nonmedical use of prescription opioids: motive and ubiquity issues. J Pain. 2008;9(6):473–86. doi:10.1016/j.jpain.2007.12.00
   PubMed Web of Science ®Google Scholar
• Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF. Defining nonmedical use of prescription opioids within health care claims: a systematic review. Subst Abus. 2015;36(2):192–202. doi:10.1080/08897077.2014.993491
   PubMed Web of Science ®Google Scholar
• Larance B, Degenhardt L, Lintzeris N, Winstock A, Mattick R. Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev. 2011;30(3):236–45. doi:10.1111/j.1465-3362.2010.00283.x
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 national survey on drug use and health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017. [accessed 2018 Jul 28]. https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-2016.pdf
   Google Scholar
• McCabe SE, West BT, Boyd CJ. Motives for medical misuse of prescription opioids among adolescents. J Pain. 2013;14(10):1208–16. doi:10.1016/j.jpain.2013.05.004
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167(5):293–301. doi:10.7326/P17-9042
   PubMed Web of Science ®Google Scholar
• Mertler CA. Introduction to educational research. Thousand Oaks, CA: Sage Publications; 2018.
   Google Scholar
• Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA. 2018;319(17):1819–21. doi:10.1001/jama.2018.2844
   PubMed Web of Science ®Google Scholar
• Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–11. doi:10.1016/j.drugpo.2017.06.010
   PubMed Web of Science ®Google Scholar
• Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’. Int J Drug Policy. 2017;46:146–55. doi:10.1016/j.drugpo.2017.06.004
   PubMed Web of Science ®Google Scholar
• US Drug Enforcement Administration. Counterfeit prescription pills containing fentanyls: a global threat [DEA Intelligence Brief; DEA-DCT-DIB-021-16]; 2016. [accessed 2018 Jul 28]. http://www.dea.gov/docs/Counterfeit%20Prescription%20Pills.pdf
   Google Scholar
• American Association of Poison Control Centers. June 2017 deadly novel synthetic opioid exposure outbreak in Georgia –a case study in the crucial surveillance role of regional poison control centers; 2017. [accessed 2018 Jul 28]. https://aapcc.s3.amazonaws.com/pdfs/releases/June_2017_Deadly_Novel_Synthetic_Opioid_Exposure_Outbreak_in_Georgia_FINAL.pdf
   Google Scholar
• Arens AM, van Wijk XM, Vo KT, Lynch KL, Wu AH, Smollin CG. Adverse effects from counterfeit alprazolam tablets. JAMA Intern Med. 2016;176(10):1554–55. doi:10.1001/jamainternmed.2016.4306
   PubMed Web of Science ®Google Scholar
• Jones CM, Baldwin GT, Compton WM. Recent increases in cocaine-related overdose deaths and the role of opioids. Am J Public Health. 2017;107(3):430–32. doi:10.2105/AJPH.2016.303627
   PubMed Web of Science ®Google Scholar
• Pichini S, Solimini R, Berretta P, Pacifici R, Busardo FP. Acute intoxications and fatalities from illicit fentanyl and analogues: an update. Ther Drug Monit. 2017;40(1):38–51. doi:10.1097/FTD.0000000000000465
   Web of Science ®Google Scholar
• Sutter ME, Gerona RR, Davis MT, Roche BM, Colby DK, Chenoweth JA, Adams AJ, et al. Fatal fentanyl: one pill can kill. Acad Emerg Med. 2017;24(1):106–13. doi:10.1111/acem.13034
   PubMed Web of Science ®Google Scholar
• Armenian P, Olson A, Anaya A, Kurtz A, Ruegner R, Gerona RR. Fentanyl and a novel synthetic opioid U-47700 masquerading as street “norco” in Central California: a case report. Ann Emerg Med. 2017;69(1):87–90. doi:10.1016/j.annemergmed.2016.06.014
   PubMed Web of Science ®Google Scholar
• Bloomberg American Health Initiative. Fentanyl overdose reduction checking analysis study. Baltimore, MD: Johns Hopkins Bloomberg School of Public Health; 2018. [accessed 2018 Jul 28]. https://idpc.net/publications/2018/02/fentanyl-overdose-reduction-checking-analysis-study
   Google Scholar
• Jones AA, Jang K, Panenka WJ, Barr AM, MacEwan GW, Thornton AE, Honer WG. Rapid change in fentanyl prevalence in a community-based, high-risk sample. JAMA Psychiatry. 2018;75(3):298–300. doi:10.1001/jamapsychiatry.2017.4432
   PubMed Web of Science ®Google Scholar
• Tourangeau R, Rips LJ, Rasinski K. The psychology of survey response. 6th ed. New York, NY: Cambridge University Press; 2006.
   Google Scholar